Video Player is loading.

Up next


To Target or Not to Target Lessons from RNAi-Based Targeted Lipid Nanoparticles- Dan Peer 2.mp4

jkase275
jkase275 - 502 Views
28
502 Views
Published on 22 Jun 2020 / In News and Politics

The efforts made to develop RNAi-based therapies have led to productive research in the field of infections in humans, such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), herpetic keratitis, human papillomavirus, or influenza virus. Naked RNAi molecules are rapidly digested by nucleases in the serum, and due to their negative surface charge, entry into the cell cytoplasm is also hampered, which makes necessary the use of delivery systems to exploit the full potential of RNAi therapeutics.

Show more
0 Comments sort Sort by

Up next